WallStSmart

Fomento Economico Mexicano (FMX)vsIDEXX Laboratories Inc (IDXX)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Fomento Economico Mexicano generates 19084% more annual revenue ($852.92B vs $4.45B). IDXX leads profitability with a 24.6% profit margin vs 3.3%. IDXX appears more attractively valued with a PEG of 4.03. IDXX earns a higher WallStSmart Score of 63/100 (C+).

FMX

Buy

54

out of 100

Grade: C-

Growth: 6.0Profit: 5.5Value: 4.3Quality: 4.3
Piotroski: 2/9Altman Z: 1.26

IDXX

Buy

63

out of 100

Grade: C+

Growth: 6.7Profit: 9.5Value: 2.7Quality: 5.0
Piotroski: 5/9
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

Intrinsic value data unavailable for FMX.

IDXXSignificantly Overvalued (-41.2%)

Margin of Safety

-41.2%

Fair Value

$459.52

Current Price

$560.11

$100.59 premium

UndervaluedFair: $459.52Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

FMX2 strengths · Avg: 9.0/10
EPS GrowthGrowth
167.8%10/10

Earnings expanding 167.8% YoY

Price/BookValuation
3.0x8/10

Reasonable price relative to book value

IDXX3 strengths · Avg: 9.7/10
Return on EquityProfitability
72.9%10/10

Every $100 of equity generates 73 in profit

Operating MarginProfitability
31.8%10/10

Strong operational efficiency at 31.8%

Profit MarginProfitability
24.6%9/10

Keeps 25 of every $100 in revenue as profit

Areas to Watch

FMX4 concerns · Avg: 3.0/10
P/E RatioValuation
26.2x4/10

Moderate valuation

Profit MarginProfitability
3.3%3/10

3.3% margin — thin

Piotroski F-ScoreQuality
2/93/10

Weak financial health signals

PEG RatioValuation
6.942/10

Expensive relative to growth rate

IDXX3 concerns · Avg: 2.0/10
PEG RatioValuation
4.032/10

Expensive relative to growth rate

P/E RatioValuation
42.0x2/10

Premium valuation, high expectations priced in

Price/BookValuation
27.8x2/10

Trading at 27.8x book value

Comparative Analysis Report

WallStSmart Research

Bull Case : FMX

The strongest argument for FMX centers on EPS Growth, Price/Book.

Bull Case : IDXX

The strongest argument for IDXX centers on Return on Equity, Operating Margin, Profit Margin. Profitability is solid with margins at 24.6% and operating margin at 31.8%. Revenue growth of 14.3% demonstrates continued momentum.

Bear Case : FMX

The primary concerns for FMX are P/E Ratio, Profit Margin, Piotroski F-Score. Thin 3.3% margins leave little buffer for downturns.

Bear Case : IDXX

The primary concerns for IDXX are PEG Ratio, P/E Ratio, Price/Book. A P/E of 42.0x leaves little room for execution misses.

Key Dynamics to Monitor

FMX profiles as a value stock while IDXX is a mature play — different risk/reward profiles.

IDXX carries more volatility with a beta of 1.57 — expect wider price swings.

IDXX is growing revenue faster at 14.3% — sustainability is the question.

FMX generates stronger free cash flow (842M), providing more financial flexibility.

Bottom Line

IDXX scores higher overall (63/100 vs 54/100), backed by strong 24.6% margins and 14.3% revenue growth. Both earn "Buy" and "Buy" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Fomento Economico Mexicano

CONSUMER DEFENSIVE · BEVERAGES - BREWERS · USA

Fomento Econmico Mexicano, SAB de CV, is a bottler of Coca-Cola brand beverages. The company is headquartered in Monterrey, Mexico.

IDEXX Laboratories Inc

HEALTHCARE · DIAGNOSTICS & RESEARCH · USA

IDEXX Laboratories, Inc. is an American multinational corporation engaged in the development, manufacture, and distribution of products and services for the companion animal veterinary, livestock and poultry, water testing, and dairy markets.

Want to dig deeper into these stocks?